Month: September 2022

ALLEGIANT GIVES $100,000 TO AMERICAN RED CROSS FOR HURRICANE RELIEF

Posted on By News Desk

Allegiant Travel Company (NASDAQ: ALGT) today announced a $100,000 donation to the American Red Cross as the nonprofit provides critical disaster relief to communities in the aftermath of Hurricane Ian. In addition, the Las Vegas-based company activated an online giving platform to empower anyone wishing to make an immediate donation to the American Red Cross….

Read More “ALLEGIANT GIVES $100,000 TO AMERICAN RED CROSS FOR HURRICANE RELIEF” »

PR Newswire

iShares® iBonds Dec 2022 Term Muni Bond ETF Nears Final Distribution Date

Posted on By News Desk

BlackRock announced today the planned termination of the iShares iBonds Dec 2022 Term Muni Bond ETF (NYSE: IBMK). IBMK’s last day of trading and final NAV calculation date will be Thursday, December 1, 2022. Its liquidation date will be Wednesday, December 7, 2022. iBonds cease trading by design, because they mature during a specific maturity…

Read More “iShares® iBonds Dec 2022 Term Muni Bond ETF Nears Final Distribution Date” »

Business Wire

Apellis Announces 24-Month Phase 3 Post Hoc Results Showing Treatment with Pegcetacoplan Led to Preservation of Function in High-Risk Areas of the Retina in Patients with Geographic Atrophy (GA) at AAO Annual Meeting

Posted on By News Desk

WALTHAM, Mass., Sept. 30, 2022 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced new data from the 24-month Phase 3 OAKS study of pegcetacoplan, an investigational targeted C3 therapy, for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration. Read more

Globe Newswire

8-K Other Events – MERIDIAN BIOSCIENCE INC (0000794172) September 30

Posted on By News Desk

Item 8.01 Other Events Litigation Relating to the Merger As previously disclosed, on July 7, 2022, Meridian Bioscience, Inc., a corporation organized under the laws of Ohio (“Meridian”), on the one hand, and SD Biosensor, Inc., a corporation with limited liability organized under the laws of the Republic of Korea, Columbus Holding Company, a corporation…

Read More “8-K Other Events – MERIDIAN BIOSCIENCE INC (0000794172) September 30” »

SEC Filings

Enterprise Quantum Computing Market Size, Research With Latest Opportunities 2022: Top Growing Factors, Dynamic Analysis And Development Suggestions, Emerging Technologies Forecast To 2028

Posted on By News Desk

Global Enterprise Quantum Computing Market Study The research report provides deep insights into global market revenue, parent market trends, macroeconomic indicators, governing factors, and market attractiveness per market segment. The report provides an overview of the growth rate of the Enterprise Read more

OpenPR

8-K Material Agrmt Reg FD – Mondee Holdings, Inc. (0001828852) September 29

Posted on By News Desk

Item 1.01 Entry into a Material Definitive Agreement Subscription Agreement On September 29, 2022, Mondee Holdings, Inc. (the “Company”) completed a private placement of the Company’s newly designated Series A Preferred Stock, par value $0.0001 per share (the “Preferred Stock”), and warrants (the “Warrants”) to purchase shares of the Company’s Class A Common Stock, par…

Read More “8-K Material Agrmt Reg FD – Mondee Holdings, Inc. (0001828852) September 29” »

SEC Filings

8-K Other Events – Trinity Capital Inc. (0001786108) September 30

Posted on By News Desk

Item 8.01 – Other Events On September 30, 2022, Trinity Capital Inc. issued a press release announcing an adjustment to the conversion rate for its 6.00% Convertible Notes due 2025. This press release is included as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. Item 9.01 – Financial Statements and Exhibits…

Read More “8-K Other Events – Trinity Capital Inc. (0001786108) September 30” »

SEC Filings
Exit mobile version